All Companies

IQV

IQVIA Holdings Inc.

Services-Commercial Physical & Biological Research

$247.56updated Jul 30, 2026

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Total Trades

6

Politicians Trading

3

Last Traded

Dec 29, 2025

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Markwayne MullinRJan 16, 2026Dec 29, 2025Buy$15,001 - $50,000+9.00%
John BoozmanRNov 15, 2025Oct 2, 2025Sell$1,001 - $15,000+21.15%
Robert BresnahanRMay 31, 2025May 15, 2025Sell$1,001 - $15,000+76.29%
Robert BresnahanRMay 8, 2025Apr 8, 2025Buy$15,001 - $50,000+71.33%
Robert BresnahanRMar 27, 2025Feb 25, 2025Sell$1,001 - $15,000+29.63%
Markwayne MullinRFeb 27, 2025Feb 13, 2025Buy$15,001 - $50,000+26.27%